SPONSOR
Centre Paul Strauss
Total Trials
4
Recruiting
4
Phases
Phase 2
Centre Paul Strauss is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Breast Neoplasms, Breast Cancer, Radiotherapy, Glioblastoma Multiforme, Adult.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Centre Paul Strauss
How many clinical trials has Centre Paul Strauss sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Centre Paul Strauss, of which 4 are actively recruiting participants. These trials cover conditions including Breast Neoplasms, Breast Cancer, Radiotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Centre Paul Strauss research focus on?
Centre Paul Strauss clinical trials span Breast Neoplasms, Breast Cancer, Radiotherapy, Glioblastoma Multiforme, Adult. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Centre Paul Strauss clinical trial?
To participate in a Centre Paul Strauss trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Centre Paul Strauss trials with current recruitment status updated daily.
Clinical Trials by Centre Paul Strauss
NCT06443645
Recruiting
Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B
Breast Neoplasms
NCT06455904
Recruiting
Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study
Breast Cancer
NCT06330142
Recruiting
Hippotherapy Teenager-pediatric Radiotherapy
Radiotherapy
NCT05653622 Phase 2
Recruiting
Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
Glioblastoma Multiforme, Adult
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology